For Patients
Development of
Optogenetic Therapeutic Approaches
Optogenetics is a new method that allows the activity of nerve cells to be controlled by light. For this purpose, the desired cell types are genetically modified to produce light-sensitive proteins (opsins). After this process, neural activity can be controlled by irradiating the cells with light. Unique to optogenetics is the control of neuronal function and the genetic targeting of specific cell types. Together, these versatile features form a powerful experimental approach. This innovative therapy method has already been followed by extensive research aimed at producing new lines of light-sensitive proteins and developing new technologies.
The goal of the Else Kröner Fresenius Center (EKFZ) for Optogenetic Therapies is to develop this novel method into innovative treatment approaches for patients suffering from the following conditions:
The technology of optogenetics promises an improvement in clinical care compared to what is currently possible or not yet possible.
